|
1
|
Yang J, Wahner-Roedler DL, Zhou X, Johnson
LA, Do A, Pachman DR, Chon TY, Salinas M, Millstine D and Bauer BA:
Acupuncture for palliative cancer pain management: Systematic
review. BMJ Support Palliat Care. 11:264–270. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang W, Rixiati Y, Zhao B, Li Y, Tang C
and Liu J: Incidence, prevalence and outcomes of systemic
malignancy with bone metastases. J Orthop Surg (Hong Kong).
28:23094990209159892020. View Article : Google Scholar
|
|
3
|
Fornetti J, Welm AL and Stewart SA:
Understanding the bone in cancer metastasis. J Bone Miner Res.
33:2099–2113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coleman RE, Croucher PI, Padhani AR,
Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R and
Costa L: Bone metastases. Nat Rev Dis Primers. 6:832020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pfister DG, Spencer S, Adelstein D, Adkins
D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ,
et al: Head and neck cancers, version 2.2020, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
18:873–898. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brozović G, Lesar N, Janev D, Bošnjak T
and Muhaxhiri B: Cancer pain and therapy. Acta Clin Croat. 61(Suppl
2): S103–S108. 2022.
|
|
7
|
Gallaway MS, Townsend JS, Shelby D and
Puckett MC: Pain among cancer survivors. Prev Chronic Dis.
17:E542020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Falk S and Dickenson AH: Pain and
nociception: Mechanisms of cancer-induced bone pain. J Clin Oncol.
32:1647–1654. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yam MF, Loh YC, Tan CS, Khadijah Adam S,
Abdul Manan N and Basir R: General pathways of pain sensation and
the major neurotransmitters involved in pain regulation. Int J Mol
Sci. 19:21642018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng XQ, Wu YH, Huang JF and Wu AM:
Neurophysiological mechanisms of cancer-induced bone pain. J Adv
Res. 35:117–127. 2021. View Article : Google Scholar
|
|
11
|
Shi Y, Gelman BB, Lisinicchia JG and Tang
SJ: Chronic-pain-associated astrocytic reaction in the spinal cord
dorsal horn of human immunodeficiency virus-infected patients. J
Neurosci. 32:10833–10840. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Göbel A, Dell'Endice S, Jaschke N, Pählig
S, Shahid A, Hofbauer LC and Rachner TD: The role of inflammation
in breast and prostate cancer metastasis to bone. Int J Mol Sci.
22:50782021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shupp AB, Kolb AD, Mukhopadhyay D and
Bussard KM: Cancer metastases to bone: Concepts, mechanisms and
interactions with bone osteoblasts. Cancers (Basel). 10:1822018.
View Article : Google Scholar
|
|
14
|
Chen R, Yin C, Fang J and Liu B: The NLRP3
inflammasome: An emerging therapeutic target for chronic pain. J
Neuroinflammation. 18:842021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moossavi M, Parsamanesh N, Bahrami A,
Atkin SL and Sahebkar A: Role of the NLRP3 inflammasome in cancer.
Mol Cancer. 17:1582018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang YZ, Zhang YL, Huang Q, Huang C,
Jiang ZL, Cai F and Shen JF: AdipoRon alleviates free fatty
acid-induced myocardial cell injury via suppressing Nlrp3
inflammasome activation. Diabetes Metab Syndr Obes. 12:2165–2179.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
D'Amico R, Fusco R, Siracusa R,
Impellizzeri D, Peritore AF, Gugliandolo E, Interdonato L, Sforza
AM, Crupi R, Cuzzocrea S, et al: Inhibition of P2X7 purinergic
receptor ameliorates fibromyalgia syndrome by suppressing NLRP3
pathway. Int J Mol Sci. 22:64712021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Corcoran SE, Halai R and Cooper MA:
Pharmacological inhibition of the Nod-like receptor family pyrin
domain containing 3 inflammasome with MCC950. Pharmacol Rev.
73:968–1000. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen SP, Zhou YQ, Wang XM, Sun J, Cao F,
HaiSam S, Ye DW and Tian YK: Pharmacological inhibition of the
NLRP3 inflammasome as a potential target for cancer-induced bone
pain. Pharmacol Res. 147:1043392019. View Article : Google Scholar
|
|
20
|
Starobova H, Monteleone M, Adolphe C,
Batoon L, Sandrock CJ, Tay B, Deuis JR, Smith AV, Mueller A, Nadar
EI, et al: Vincristine-induced peripheral neuropathy is driven by
canonical NLRP3 activation and IL-1β release. J Exp Med.
218:e202014522021. View Article : Google Scholar
|
|
21
|
Seidel C, Schnekenburger M, Dicato M and
Diederich M: Histone deacetylase 6 in health and disease.
Epigenomics. 7:103–118. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
English K and Barton MC: HDAC6: A key link
between mitochondria and development of peripheral neuropathy.
Front Mol Neurosci. 14:6847142021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen S, Picci C, Ustinova K, Benoy V,
Kutil Z, Zhang G, Tavares MT, Pavlíček J, Zimprich CA, et al:
Tetrahydroquinoline-capped histone deacetylase 6 inhibitor SW-101
ameliorates pathological phenotypes in a charcot-marie-tooth type
2A mouse model. J Med Chem. 64:4810–4840. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Van Helleputte L, Kater M, Cook DP, Eykens
C, Rossaert E, Haeck W, Jaspers T, Geens N, Vanden Berghe P,
Gysemans C, et al: Inhibition of histone deacetylase 6 (HDAC6)
protects against vincristine-induced peripheral neuropathies and
inhibits tumor growth. Neurobiol Dis. 111:59–69. 2018. View Article : Google Scholar
|
|
25
|
Krukowski K, Ma J, Golonzhka O, Laumet GO,
Gutti T, van Duzer JH, Mazitschek R, Jarpe MB, Heijnen CJ and
Kavelaars A: HDAC6 inhibition effectively reverses
chemotherapy-induced peripheral neuropathy. Pain. 158:1126–1137.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prior R, Van Helleputte L, Klingl YE and
Van Den Bosch L: HDAC6 as a potential therapeutic target for
peripheral nerve disorders. Expert Opin Ther Targets. 22:993–1007.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang P, Li H, Hu H, Li Y and Wang T: The
role of HDAC6 in autophagy and NLRP3 inflammasome. Front Immunol.
12:7638312021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan S, Wei X, Jian W, Qin Y, Liu J, Zhu S,
Jiang F, Lou H and Zhang B: Pharmacological inhibition of HDAC6
attenuates NLRP3 inflammatory response and protects dopaminergic
neurons in experimental models of parkinson's disease. Front Aging
Neurosci. 12:782020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Magupalli VG, Negro R, Tian Y, Hauenstein
AV, Di Caprio G, Skillern W, Deng Q, Orning P, Alam HB, Maliga Z,
et al: HDAC6 mediates an aggresome-like mechanism for NLRP3 and
pyrin inflammasome activation. Science. 369:eaas89952020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu X, Zhang H, Qi W, Zhang Y, Li J, Li Z,
Lin Y, Bai X, Liu X, Chen X, et al: Nicotine promotes
atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis.
Cell Death Dis. 9:1712018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Godena VK, Brookes-Hocking N, Moller A,
Shaw G, Oswald M, Sancho RM, Miller CC, Whitworth AJ and De Vos KJ:
Increasing microtubule acetylation rescues axonal transport and
locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat
Commun. 5:52452014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao FD, Yang JQ, Huang YC, Luo MP, Yang
WJ, Zhang B and Liu XJ: Antinociceptive effects of ginsenoside Rb1
in a rat model of cancer-induced bone pain. Exp Ther Med.
17:3859–3866. 2019.PubMed/NCBI
|
|
33
|
Hou X, Weng Y, Ouyang B, Ding Z, Song Z,
Zou W, Huang C and Guo Q: HDAC inhibitor TSA ameliorates mechanical
hypersensitivity and potentiates analgesic effect of morphine in a
rat model of bone cancer pain by restoring μ-opioid receptor in
spinal cord. Brain Res. 1669:97–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu M, Cheng X, Yan H, Chen J, Liu C and
Chen Z: MiR-135-5p alleviates bone cancer pain by regulating
astrocyte-mediated neuroinflammation in spinal cord through
JAK2/STAT3 signaling pathway. Mol Neurobiol. 58:4802–4815. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dixon WJ: Efficient analysis of
experimental observations. Annu Rev Pharmacol Toxicol. 20:441–62.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi X, Bai H, Wang J, Wang J, Huang L, He
M, Zheng X, Duan Z, Chen D, Zhang J, et al: Behavioral assessment
of sensory, motor, emotion and cognition in rodent models of
intracerebral hemorrhage. Front Neurol. 12:6675112021. View Article : Google Scholar
|
|
37
|
Song ZP, Xiong BR, Guan XH, Cao F,
Manyande A, Zhou YQ, Zheng H and Tian YK: Minocycline attenuates
bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.
Acta Pharmacol Sin. 37:753–762. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song S, Guo R, Mehmood A, Zhang L, Yin B,
Yuan C, Zhang H, Guo L and Li B: Liraglutide attenuate central
nervous inflammation and demyelination through AMPK and
pyroptosis-related NLRP3 pathway. CNS Neurosci Ther. 28:422–434.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen C, Liu A, Lu Q, Luo L, Li J, Ke J,
Liu Y and Feng X: HDAC6 inhibitor ACY-1215 improves neuropathic
pain and its comorbidities in rats of peripheral nerve injury by
regulating neuroinflammation. Chem Biol Interact. 353:1098032022.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mazzetti S, De Leonardis M, Gagliardi G,
Calogero AM, Basellini MJ, Madaschi L, Costa I, Cacciatore F,
Spinello S, Bramerio M, et al: Phospho-HDAC6 gathers into protein
aggregates in parkinson's disease and atypical parkinsonisms. Front
Neurosci. 14:6242020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dong ZB, Wang YJ, Wan WJ, Wu J, Wang BJ,
Zhu HL, Xie M and Liu L: Resveratrol ameliorates
oxaliplatin-induced neuropathic pain via anti-inflammatory effects
in rats. Exp Ther Med. 24:5862022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hol EM and Pekny M: Glial fibrillary
acidic protein (GFAP) and the astrocyte intermediate filament
system in diseases of the central nervous system. Curr Opin Cell
Biol. 32:121–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vallee KJ and Fields JA: Caloric
restriction mimetic 2-deoxyglucose reduces inflammatory signaling
in human astrocytes: Implications for therapeutic strategies
targeting neurodegenerative diseases. Brain Sci. 12:3082022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gharagozloo M, Smith MD, Jin J, Garton T,
Taylor M, Chao A, Meyers K, Kornberg MD, Zack DJ, Ohayon J, et al:
Complement component 3 from astrocytes mediates retinal ganglion
cell loss during neuroinflammation. Acta Neuropathol. 142:899–915.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mao Y, Zhou J, Liu X, Gu E, Zhang Z and
Tao W: Comparison of different histone deacetylase inhibitors in
attenuating inflammatory pain in rats. Pain Res Manag.
2019:16489192019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xu J, Zhao X, Jiang X, He L, Wu X, Wang J,
Chen Q, Li Y and Zhang M: Tubastatin A Improves post-resuscitation
myocardial dysfunction by inhibiting NLRP3-mediated pyroptosis
through enhancing transcription factor EB signaling. J Am Heart
Assoc. 11:e0242052022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhao J, Yan Y, Zhen S, Yu L, Ding J, Tang
Q, Liu L, Zhu H and Xie M: LY294002 alleviates bone cancer pain by
reducing mitochondrial dysfunction and the inflammatory response.
Int J Mol Med. 51:422023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen J, Cong X, Zhan X, Zhou Z and Zheng
W: Effects of parecoxib on pain threshold and inflammatory factors
IL-1β, IL-6 and TNF-α in spinal cord of rats with bone cancer pain.
J Coll Physicians Surg Pak. 29:528–531. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ji RR, Berta T and Nedergaard M: Glia and
pain: Is chronic pain a gliopathy? Pain. 154(Suppl 1): S10–S28.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen G, Zhang YQ, Qadri YJ, Serhan CN and
Ji RR: Microglia in pain: Detrimental and Protective roles in
pathogenesis and resolution of pain. Neuron. 100:1292–1311. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ji RR, Donnelly CR and Nedergaard M:
Astrocytes in chronic pain and itch. Nat Rev Neurosci. 20:667–685.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hwang I, Lee E, Jeon SA and Yu JW: Histone
deacetylase 6 negatively regulates NLRP3 inflammasome activation.
Biochem Biophys Res Commun. 467:973–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang CJ, Liu YP, Dai HY, Shiue YL, Tsai
CJ, Huang MS and Yeh YT: Nuclear HDAC6 inhibits invasion by
suppressing NF-κB/MMP2 and is inversely associated with metastasis
of non-small cell lung cancer. Oncotarget. 6:30263–30276. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Barter MJ, Butcher A, Wang H, Tsompani D,
Galler M, Rumsby EL, Culley KL, Clark IM and Young DA: HDAC6
regulates NF-κB signalling to control chondrocyte IL-1-induced MMP
and inflammatory gene expression. Sci Rep. 12:66402022. View Article : Google Scholar
|
|
55
|
Wright LE, Ottewell PD, Rucci N,
Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT and Sterling JA:
Murine models of breast cancer bone metastasis. Bonekey Rep.
5:8042016. View Article : Google Scholar : PubMed/NCBI
|
